Perioperative Role Of Vascular Endothelial Growth Factor In Cardiac Surgery-associated Acute Kidney Injury

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversität Münster

About this trial

The goal of this prospective observational study is to find out whether the protein vascular endothelial growth factor (VEGF) measured in blood and urine can predict which patients will develop acute kidney injury (AKI) after heart-type surgery that uses a heart-lung machine (cardiopulmonary bypass).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years

Elective cardiac surgery using cardiopulmonary bypass

Written informed consent

Disqualifiers

Pre-existing chronic kidney disease with an eGFR <20 ml/min/1,73m2

Usage of VEGF-inhibitors

Patients with pre-existing AKI within the last 30 days

Emergency surgery

Trial population

Adult patients undergoing elective cardiac surgery with use of cardiopulmonary bypass

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

220 Participants
are grouped into 1 trial group
Group A: Elective cardiac surgical patients

Trial outcomes

Primary outcomes

1

Association of vascular endothelial growth factor (VEGF) levels with postoperative acute kidney injury

Time frame
From baseline to postoperative day 3

Secondary outcomes

1

Difference in VEGF levels between patients with and without chronic kidney disease

Time frame
From Baseline to postoperative day 3
2

Difference in VEGF levels between patients with transient and persistent acute kidney injury (AKI) after cardiac surgery

Comparison of VEGF levels between patients with transient AKI (resolving within 48 hours of onset) and persistent AKI (lasting more than 48 hours), among patients who develop AKI within the first 3 postoperative days following cardiac surgery.

Time frame
Up to 30 days postoperatively
3

Association of VEGF levels with length of ICU-stay

Association between perioperative VEGF levels and the duration of index intensive care unit (ICU) stay following cardiac surgery.

Time frame
Up to 30 days postoperatively
4

Association of VEGF levels with length of hospital stay

Association between perioperative VEGF levels and the duration of index hospital stay following cardiac surgery.

Time frame
Up to 30 days postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: